- Category
- Micro (2023-24)
- Udyam number
- UDYAM-TS-20-0036221

Strigine Pharmaceuticals Private Limited
About Strigine Pharmaceuticals Private Limited
Data last updated:
Strigine Pharmaceuticals Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 23 June 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24230TG2020PTC141047. Its GSTIN is 36ABDCS8176L1ZO (Telangana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Srilakshmi Nannuri Suryanarayana Rao and Edara Hari Babu.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2023, the company reported a revenue of ₹94,422, a growth of 8% compared to the previous year. For the same year it recorded a net loss of ₹45,960 (net margin -48.7%) and EBITDA of -₹45,960 (EBITDA margin -48.7%).
Strigine Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0036221).
Company details
Recognitions & Rankings of Strigine Pharmaceuticals
Contact details
Strigine Pharmaceuticals Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressPlot No: 177 4th Floor Lahari Estates Opp Vijetha Super Market Pragathi Nagar, Kukatpally, Hyderabad, Telangana, India – 500090
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Strigine Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Strigine Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Strigine Pharmaceuticals Private Limited, buy the company report.
Financials of Strigine Pharmaceuticals Private Limited
FY 2023 filings availableStrigine Pharmaceuticals Private Limited reported revenue of ₹94,422 (up 8% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue rose 8% in the latest year. EBITDA fell 48% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹45,960 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹45,960 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -48.7% | ||
| Net Profit Margin | -48.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Strigine Pharmaceuticals Private Limited, buy the company report.
Board of directors of Strigine Pharmaceuticals Private Limited
Strigine Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srilakshmi Nannuri Suryanarayana Rao | Director | 23 Jun 2020 | 6 Years 4 Months | Current |
| Edara Hari Babu | Director | 25 May 2022 | 4 Years 5 Months | Current |
Legal cases
No court or tribunal cases involving Strigine Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Strigine Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Strigine Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABDCS8176L1ZO | Telangana | Active | 22 Sep 2020 |
To see the full GST registrations and return filing status of Strigine Pharmaceuticals Private Limited, buy the company report.
Recent activity
Strigine Pharmaceuticals Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Edara Hari Babu was appointed as Director on 25 May 2022.
Frequently asked questions
Strigine Pharmaceuticals is an active private limited company based in Hyderabad, Telangana, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 23 June 2020 (6+ years old) and is registered under CIN U24230TG2020PTC141047.
Strigine Pharmaceuticals has 2 current directors:
- Srilakshmi Nannuri Suryanarayana Rao - Director
- Edara Hari Babu - Director
The latest financial statements of Strigine Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Strigine Pharmaceuticals is 36ABDCS8176L1ZO, registered in Telangana.
The CIN (Corporate Identification Number) of Strigine Pharmaceuticals is U24230TG2020PTC141047. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Strigine Pharmaceuticals was incorporated on 23 June 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
Edara Hari Babu was appointed as Director on 25 May 2022. Srikanthreddy Kolli ceased to be Director on 25 May 2022. Sushma Marupudi ceased to be Director on 25 May 2022. Strigine Pharmaceuticals has 4 board changes on record in total.
Yes, Strigine Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0036221).
The registered office of Strigine Pharmaceuticals is at Plot No: 177 4th Floor Lahari Estates Opp Vijetha Super Market Pragathi Nagar, Kukatpally, Hyderabad, Telangana, India – 500090.
Strigine Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.

